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abstract
Background: Streptococcus mutans (S. mutans) is a bacterium that plays an important role in the pathogenesis of dental caries. 
Streptococcus mutans produces the glucosyltransferase enzyme which is capable of catalyzing glucan synthesis in the progression of 
dental caries. Certain treatments involving traditional plant use have been developed to eradicate Streptococcus mutans as a means of 
preventing the formation of dental caries. One of these is mangosteen pericarp extract containing a number of polyphenols that have 
the capacity to act as antibacterial agents, namely; tannin, mangostin, and flavonoid. Purpose: The study aimed to investigate the 
inhibitory power of mangosteen pericarp extract against Streptococcus mutans producing the glucosyltransferase enzyme. Methods: 
The research used mangosteen pericarp extract at concentrations of 0.39% and 0.78% as the treatments, while 0.12% chlorhexidine 
gluconate was used as a positive control, and distilled water as a negative control. Each group consisted of six samples. Mangosteen 
peels extracted with 96% ethanol (maceration method) and mangosteen extract constituted 5% of the total weight of the mangosteen 
pericarp. Supernatant containing Gtf enzyme produced from a culture medium and centrifuged at 1500 rpm for 10 minutes at 4o C. 
Glucosyltransferase enzyme activity was measured by analyzing the extensive fructose area by means of High Performance Liquid 
Chromatography (HPLC). The extensive fructose area was determined according to time retention in each group. Results: Mangosteen 
peel extract at concentrations of 0.39% and 0.78% demonstrated greater ability than the negative control group (sterile aquades) and 
similar ability to the positive group (chlorhexidine 0.12%) to inhibit the activity of the Gtf enzyme or S. mutans bacteria. Conclusion: 
Mangosteen pericarp extract has the ability to inhibit the activity of Streptococcus mutans in producing glucosyltransferase enzyme.
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introduction
According to the Basic Health Research (RISKESDAS) 
project of 2013, the DMF-T index of the Indonesian 
population was 4.6, categorized as ‘high’ by the World 
Health Organization (WHO). The high prevalence 
of dental caries cannot, in fact, be separated from the 
virulent properties of cariogenic bacteria in the oral 
cavity.1 Cariogenic bacteria, together with fermentable 
carbohydrates and saliva, contributes to the demineralization 
cycle and dental remineralization. The main cariogenic 
bacterium responsible for dental caries is Streptococcus 
mutans (S. mutans), also considered to be the dominant 
bacterium in the oral cavity.2
S. mutans produces the glucosyltransferase (Gtf) 
enzyme, a virulent factor in dental caries pathogens. The 
Gtf enzyme can catalyze the formation of soluble and 
insoluble glucan derived from sucrose, while also playing 
a significant role in the polysaccharide matrix composition 
of dental plaque. This is because glucan can support both 
the attachment to and accumulation on tooth surfaces of 
cariogenic S. mutans bacteria. As a result, the activity of 
the Gtf enzyme generated by S. mutans bacteria should be 
inhibited in order to prevent dental caries.3
In the field of dentistry, certain antiseptics and other 
substances, including chlorhexidine, triclosan, and 
sanguinarine, are often used as dental plaque control 
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agents. One antibacterial material considered to be the 
gold standard in the field of dentistry is chlorhexidine. 
Nevertheless, it still manifests several deficiencies leading 
to tooth discoloration and discomfort. Consequently, further 
research should focus on the development of a new, specific 
agent capable of inhibiting Gtf enzyme activity as a means 
of controlling the formation of dental plaque with minimal 
side effects on the oral cavity.4
New agents the medical benefits of which have been 
investigated are naturally occurring materials enjoying 
wide availability and limited side effects. One frequently 
used natural material whose benefits are particularly well-
known throughout Southeast Asia is mangosteen (Garcinia 
mangostana L.). This fruit or, more specifically, its peel 
provides many benefits contains several compounds 
producing a range of pharmacological benefits, including; 
anti-aging, anti-bacterial, anti-viral and anti-hypertension.5 
The results of laboratory tests confirm that mangosteen peel 
extract contains a range of elements, including; xhantone 
(10.70%), saponin (3.82%), tannins (5.92%), αα-mangostin 
(2.82%), b mangostin (7.88%), flavonoids (1.88%), and 
mangostanin (11.88%).6
S. mutans produce three Gtf enzymes: GtfB synthesizes 
the insoluble glucan alpha (1-3) polymer, GtfC synthesizes 
a mixture of insoluble glucan alpha (1-3) and non-alpha 
soluble (1-6), whereas GtfD synthesizes soluble glucan 
alpha (1-6). The content of flavonoids and alpha αα-
mangostin in mangosteen pericarp extract is effective in 
inhibiting GtfB and GtfC enzymes restricting their activity 
by up to 70%. However, the main one is GtfB because it 
can catalyze the formation of insoluble, alfa-linked glucan.7 
Inhibition of enzyme activity is also known to be caused 
by tannin which has an inhibitory power of 31.39%.8 In 
addition, flavonoids also actively limit the activity of the 
Gtf enzyme as well as promoting antibacterial activity. 
Nevertheless, such compounds have been shown 
to be effective in inhibiting the activity of Gtf enzyme. 
Unfortunately, no research has yet been conducted into the 
inhibitory power of a natural material containing all three 
compounds with regard to the activity of Gtf enzymes. Thus, 
mangosteen peel, containing flavonoids, α-mangostin, and 
tannins, is thought to be effective in inhibiting the activity 
of Gtf enzymes. Mangosteen pericarp extract is also 
known to be capable of inhibiting and killing S. mutans 
bacteria. The minimum inhibitory concentration (MIC) 
of the mangosteen pericarp extract on S. mutans bacteria 
is 0.39%, while its minimum bactericidal concentration 
(MBC) is 0.78%.6
Further investigations would be most appropriately 
focused on the MIC and MBC of the mangosteen pericarp 
extract since it is expected to be an alternative ingredient 
of mouthwash within its MIC range. Moreover, this 
research was also expected to analyze the mangosteen 
pericarp extract within the concentration range of MIC and 
MBC. Therefore, the activity of the Gtf enzyme can still 
continue even though S.mutans bacteria have died within 
the concentration range of MBC.9 
materials and methods
The research reported here was an experimental 
laboratory-based study with randomized control group 
post test-only design. Research samples consisted of 
S. mutans bacteria obtained from the Laboratory of 
Microbiology, Faculty of Dental Medicine, Universitas 
Airlangga, Indonesia. The number of samples totaled six 
in accordance with Federer’s formula (1963). Independent 
variables consisted of the mangosteen pericarp extract at 
concentrations of 0.39% and 0.78%, while the dependent 
variable was the activity of Gtf enzyme generated by S. 
mutans bacteria.
Mangosteen pericarp extract was prepared at Materia 
Medika, Batu, East Java, Indonesia. Meanwhile, the first 
preparation of S. mutans bacteria was conducted in the 
Laboratory of Microbiology, Faculty of Dental Medicine, 
Universitas Airlangga, Indonesia. Subsequently, the second 
preparation of S. mutans bacteria was performed at Institute 
of Tropical Disease, Universitas Airlangga, Indonesia. 
Thereafter, Gtf enzyme was extracted from S. mutans 
bacteria and tested at Central Testing Services, Faculty of 
Pharmacy, Universitas Airlangga, Indonesia.
Mangosteen pericarp extract was prepared by treating 
dried mangosteen pericarp with 96% ethanol solvent and 
water using a maceration method. Consequently, all less 
polar, semi polar and polar chemicals could be extracted 
as far as possible. The ratio of 96% ethanol solvent to 
mangosteen peel powder used was 1:2. The maceration 
method is a filtration process of simplicia derived from 
solvent by agitating the latter several times and then stirring 
it with a Gerhardt Thermoshaker, Germany (2 x 24 hours) 
at room temperature. The simplica was then filtered, the 
resulting clear red filtrates being evaporated with a vacuum 
evaporator (at 60o C) until the ethanol separated out. Brown 
mangosteen pericarp extract accounting for 5% of the total 
weight of the mangosteen pericarp was then produced.
The S. mutans bacteria used in this research were drawn 
from S. mutans stock and then injected into BHIB (Brain 
Heart Infusion Broth) media before being incubated for 
24 hours at 37° C. After cultivation for 24 hours, a sterile 
tube containing S. mutans bacteria was prepared in 7 mL of 
BHIB, incubated at 37° C for 24 hours and, finally, vibrated 
at 150 rpm with a Gerhardt Thermoshaker, Germany.10 
Next, the culture media were centrifuged at 1500 rpm using 
an Ultra Sentrifugator Hermle Z36HK for 10 min at 4° C, 
generating supernatants containing the Gtf enzyme.11
Twenty-four test tubes were subsequently utilised 
during this investigation, six of which were used for each 
research group, namely the positive control group, the 
negative control group, the treatment group using the 
mangosteen pericarp extract at a concentration of 0.39%, 
and the treatment group using the extract at a concentration 
of 0.78%. The positive control tubes contained 0.875 ml of 
0.25 M sucrose in 0.2 M phosphate buffer with pH of 7, then 
supplemented with 0.1 ml of Gtf enzyme solution and 0.025 
ml of 0.12% chlorhexidine. The negative control tubes, on 
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the other hand, contained 0.875 ml of 0.25 M sucrose in 
0.2 M phosphate buffer with pH of 7, then supplemented 
with 0.1 ml of Gtf enzyme solution and 0.025 ml of sterile 
aquadest. In addition, tubes in the first treatment group 
contained 0.875 ml of 0.25 M sucrose in a 0.2 M phosphate 
buffer with pH 7, then supplemented with 0.1 ml of the 
Gtf enzyme solution and 0.025 ml of the mangosteen peel 
extract at a concentration of 0.39%. Meanwhile, tubes in 
the second treatment group contained 0.875 ml of 0.25 
M sucrose in a 0.2 M phosphate buffer with pH 7, then 
supplemented with 0.1 ml of the Gtf enzyme solution and 
0.025 ml of the mangosteen peel extract at a concentration 
of 0.78%. All such treatment and control materials were 
then incubated at 370 C for two hours.
After incubation and filtering with 0.45 μm, filter 
papers, the fructose concentration was tested by means of 
a high performance liquid chromatography (HPLC Agilent, 
USA), i.e. by injecting 20 μl of the treatment solution or 
control solution to reveal their retention time. Fructose 
levels were then calculated by reading the area of  fructose 
in the standard solution as follows:12 
Concentration (%) = 
Note:
AC = sample area
AS = standard area
VIC = volume of sample injection
VIS = volume of standard injection
KS = standard concentration
FP = dilution factor
The results of the fructose standard solution test on 
HPLC in this research showed that the retention time 
for fructose was approximately 2.8 minutes. The area of 
fructose generated in each sample can be indicated by the 
retention time shown on the chromatogram. 
The normality test is performed to calculate normally 
distributed data, with Levene’s test being subsequently 
performed to calculate the homogeneity of the data. The 
next calculation uses the Kruskal Walles test to calculate 
the differences between groups. The value of significance 
between groups is established through application of the 
Mann-Witney test.
results
The results of the reading and measuring of fructose 
levels with HPLC are divided into the control groups and 
the treatment groups using the mangosteen pericarp extract 
(Figure 1).
The results of the normality test revealed the significance 
value to be greater than 0.05. This suggests that the 
data for all research groups was normally distributed. 
Meanwhile, the Levene’s test results showed a significance 
value of 0.000 (p<0.05) indicating that the data was not 
homogeneous. The results of the Kruskal-Wallis test 
indicated a significance value of 0.001 (p<0.05), indicating 
that there were significant differences between the research 
groups.
To reveal the significance value in each group, a Mann-
Whitney test was performed the results of which can be seen 
in Table 1. The negative control group (sterile aquades) 
Table 1. Results of the Mann-Whitney test
Negative Control Positive Control Treatment Group 1 Treatment Group 2
Negative control
(aquades sterile)
– p value= 0,002* p value= 0.002* p value= 0,002*
Positive control
(chlorhexidine 0,12%)
– – p value= 0,065 p value= 0,180
Treatment Group 1
(0,39%)
– – – p value= 0,180
Treatment Group 2
(0,78%)
– – – -
Note:
(+) = The positive control group using 0.12% chlorhexidine 
(-) =  The negative control group using sterile aquadest 
I = The treatment Group I using mangosteen pericarp extract at the concentrations of 0.39% 
II =  The treatment Group I using mangosteen pericarp extract at the concentrations of 0.78%
120
100
80
60
40
20
0
%
Control (+) Control (–)
 Mean (%)
Treatment 1 Treatment 2
Figure 1. The mean and SD level of fructose in the control and 
treatment groups. 
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ability’s to inhibit Gtf S. mutans enzyme (p=0.002) 
was significantly lower than that of the positive control 
group (chlorhexidine 0.12%), and the 0.78% mangosteen 
pericarp extract group. The negative control group’s (sterile 
aquades) ability to inhibit Gtf S.mutans enzyme (p=0.002) 
was significantly lower than that of the treatment group 
of 0.39% mangosteen pericarp extract. The mangosteen 
pericarp extract concentration group of 0.39% and 0.78% 
manifested the same ability as the positive control group 
(chlorhexidine 0.12%) as a substance which could inhibit 
the bacterial Gtf S. mutans. 
discussion
The research results showed that the concentration of 
fructose in the negative control group had a higher value 
(94.5%) than that the other treatment groups. The elevated 
concentration of fructose indicated the level of activity 
of S. mutans Gtf enzyme in catalyzing the breakdown of 
sucrose. This was due to the solution in the reaction tube 
of the negative control containing sucrose, Gtf enzyme, 
and aquadest. Since aquadest was neutral, the enzyme 
broke the sucrose down into fructose and glucose without 
difficulty.
Polyphenol compounds in mangosteen pericarp extract 
are, moreover, reported as inhibiting the activity of the Gtf 
enzyme. Polyphenol compounds consist of flavonoids, 
tannins, and α mangostin and can inhibit the activity of 
the Gtf enzyme by destroying other enzymes and microbial 
proteins. Therefore, this enzyme which is mostly composed 
of proteins can be denatured by the polyphenol compounds 
generated by the mangosteen pericarp extract.13 Flavonoids 
playing a role in the inhibition of the Gtf enzyme are 
flavones and flavonols since both compounds have double 
bonds between C-2 and C-3 atoms in their chemical 
structure chains. The existence of this double bond provides 
a space for nucleophilic addition (a tendency to donate 
electrons or react with fewer electron sites, such as protons). 
The side chain of the Gtf enzyme in the form of aspartic 
acid (CH2COOH) then possibly acts as a nucleophile and 
reacts with flavones and flavonols, thereby causing the Gtf 
enzyme to be inhibited.3 
Another polyphenolic compound is tannin, which 
features a hydroxyl group in its structure, which potentially 
leads to a redoxive reaction with the Gtf enzyme. This 
reaction, in turn, triggers the inhibition of Gtf enzyme 
activity. The redoxive reaction is an oxidation-reduction 
reaction involving the exchange of electrons between two 
chemical structures. Tannins can inhibit Gtf enzyme activity 
by 31.93%.8 Meanwhile, the third polyphenol compound 
in the mangosteen pericarp extract, α mangostin, inhibiting 
the activity of the Gtf enzyme was investigated by means 
of docking studies. Such studies predict the affinity and 
conformity of a molecule against a target protein. The 
molecule studied was α mangostin, while the target protein 
was the Gtf enzyme. In the results of that research, amino 
acids in the chain of the Gtf enzyme were found to be 
strongly and stably bound with α mangostin, indicating 
the effects of α mangostin on the Gtf enzyme.7
Based on the results of the analysis of those treatment 
groups using mangosteen pericarp extract, it could be seen 
that this extract at a concentration of 0.78% had greater 
inhibitory power against the activity of the Gtf enzyme 
(with a fructose level of 32.63%) than the mangosteen 
pericarp extract at a concentration of 0.39% (with a fructose 
level of 49.77%). Nevertheless, the results of the Mann-
Whitney test showed there to be no significant difference 
between the two treatment groups. As a result, it could be 
concluded that the mangosteen pericarp extract at both 
concentrations had almost the same inhibitory power.
Meanwhile, the positive control group used 0.12% 
chlorhexidine since this material is the gold standard 
of material used in mouthwash. Chlorhexidine is an 
antibacterial active ingredient that is relatively effective 
compared to other antibacterial agents. In addition, 
chlorhexidine also can inhibit the activity of the Gtf 
enzyme. Chlorhexidine at bacteriostatic concentrations can 
even inhibit membrane enzymes and disrupt the interaction 
between lipids and proteins in the membrane. Consequently, 
chlorhexidine can inhibit the S. mutans glucosyltransferase 
enzyme and denature the enzyme protein.14 Similarly, in 
this research, the fructose level was significantly lower 
than in the negative control group, indicating that 0.12% 
chlorhexidine was effective in inhibiting the activity of 
the Gtf enzyme. The fructose level in the positive control 
group was 25.87%, lower than that in the treatment groups 
using the mangosteen pericarp extract. This suggests that 
chlorhexidine had an inhibitory effect against Gtf enzymes 
superior to that of the mangosteen pericarp extract.
In addition, the results of the Mann-Whitney test 
showed that the significance value between the positive 
control group and treatment Group I was 0.065 (p>0.05), 
while that between the positive control group and treatment 
Group II was 0.180 (p>0.05). This means that there was no 
significant difference between the positive control group 
and those two treatment groups using the mangosteen 
pericarp extract at respective concentrations of 0.39% of 
0.78%. In other words, the ability of mangosteen pericarp 
extract at these concentrations was equivalent to that of 
chlorhexidine at the concentration of 0.12% used as the 
positive control. 
In conclusion, mangosteen pericarp extract (at 
concentrations of 0.39% and 0.78%) demonstrated 
inhibitory power against the activity of S. mutans producing 
Gtf enzyme. However, it proved less effective in this regard 
than 0.12% chlorhexidine.
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